表紙
市場調查報告書

末梢血管設備的美國市場

Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite

出版商 iData Research Inc. 商品編碼 922435
出版日期 內容資訊 英文 997 Pages
商品交期: 最快1-2個工作天內
價格
末梢血管設備的美國市場 Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite
出版日期: 2020年01月13日內容資訊: 英文 997 Pages
簡介

本報告提供美國的末梢血管設備市場相關調查,提供市場趨勢,疾病概要,各疾病·類型產品的分析與預測,成長促進因素·阻礙成長的要素,競爭情形,手術數量等系統性資訊。

目錄

摘要整理

美國的末稍血管設備市場概要

競爭分析

市場趨勢

調查方法

市場開發

手術數量

調查對象的手術編碼

對象市場

主要報告的更新

版本履歷

調查方法

疾病概要

  • 基本解剖學
  • 疾病的治療和診斷
    • 主動脈瘤
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
    • 深部靜脈血栓症(DVT)
    • 肺動脈栓塞(PE)
  • 患者統計
    • 主動脈瘤
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
    • 深部靜脈血栓症(DVT)
    • 肺動脈栓塞(PE)

產品評估

  • 簡介
  • 產品系列
    • 末梢血管支架
    • 靜脈支架
    • 經皮血管成形術(PTA)球囊
    • 藥物塗層氣球 (DCB)
    • 旋切術設備
    • 慢性完全閉塞病變(CTO)設備
    • 血管內碎石術
    • 外科移植
    • 血管支架
    • 栓塞保護裝置
    • 週邊血栓管理設備
    • 下腔靜脈濾器
    • 頸動脈分流術
    • 診斷·介入性導管
    • 診斷·介入性導管導引線
    • 導管鞘
    • 血管閉合設備(VCD)
    • 經導管栓塞治療裝置
    • 末梢IVUS (血管內超音波) 導管
  • 法規上的問題·回收
    • Abbott
    • Argon Medical
    • Arrow International
    • Atrium Medical
    • BD
    • Boston Scientific
    • Cardinal Health
    • Cardiovascular System (C.S.I.)
    • Cook Medical
    • Cordis (Cardinal Health)
    • Endologix
    • Edwards Lifesciences
    • Maquet
    • Medtronic
    • Spectranetics (Philips)
    • Shockwave Medical, Inc.
    • Terumo Corporation
    • 其他的企業
  • 臨床試驗
      Abbott
    • B. Braun
    • Boston Scientific
    • C.R. Bard (BD)
    • Cardinal Health
    • Cook Medical
    • Cordis (Cardinal Health)
    • Medtronic
    • Merit Medical
    • Philips/Spectranetics
    • Shockwave Medical, Inc.
    • Surmodics
    • Terumo
    • W.L. Gore
    • 其他的企業

美國的末稍血管設備市場概要

  • 簡介
    • 動脈粥狀硬化
    • 週邊動脈疾病(PAD)
  • 市場概要
  • 趨勢分析:各市場區隔
  • 促進成長要素與阻礙因素
    • 推動市場要素
    • 阻礙市場要素
  • 競爭市場佔有率分析
  • 合併和收購
  • 企業簡介
    • Abbott
    • Becton Dickinson (BD)
    • Boston Scientific
    • Cardinal Health
    • Cook Medical
    • Maquet
    • Medtronic
    • Teleflex
    • Terumo Interventional System (TIS)
    • W.L. Gore
  • SWOT分析
    • Abbott
    • B. Braun
    • Boston Scientific
    • BD
    • Cardinal Health
    • Cook Medical
    • Integra Lifesciences
    • Maquet
    • Medtronic
    • Merit Medical
    • Phillips
    • Teleflex
    • Terumo
    • W.L. Gore

手術數量

  • 簡介
  • 手術數量
    • 末稍血管手術數量
    • 末稍血管手術數量:設備的種類,適應症,干預,醫療環境
    • 末梢血管支架治療數量
    • 末梢靜脈支架治療數量
    • PTA球囊導管治療數量
    • 藥物塗層氣球治療數量
    • 動脈粥狀硬化斑塊切除術治療數量

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USPV20_MS

The U.S. peripheral vascular device market was valued at $7.1 billion in 2019. This is expected to increase over the forecast period at a CAGR of 5.6% to reach $10.4 billion.

One of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital.

The release of the paclitaxel meta-analysis by Katsanos in late 2018 raised serious concern about the late mortality of drug-coated balloons (DCB) and drug-eluting stents (DES). At the start of 2019, the FDA announced that they would reexamine the safety of paclitaxel products in the peripheries. A large movement occurred shortly after, away from paclitaxel devices and towards more traditional devices. Although the FDA released a statement in August 2019 stating that they were not able to identify a late-mortality signal caused by paclitaxel use in the peripheries, hesitancy about the use of these devices remain.

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

    • 1.1.1 Step 1: Project Initiation & Team Selection
    • 1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
    • 1.1.3 Step 3: Preparation for Interviews & Questionnaire Design
    • 1.1.4 Step 4: Performing Primary Research
    • 1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
    • 1.1.6 Step 6: Market Forecast and Analysis
    • 1.1.7 Step 7: Identify Strategic Opportunities
    • 1.1.8 Step 8: Final Review and Market Release
    • 1.1.9 Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1 BASIC ANATOMY
  • 2.2 DISEASE TREATMENTS & DIAGNOSTICS
    • 2.2.1 Aortic Aneurysms
    • 2.2.2 Atherosclerosis
    • 2.2.3 Peripheral Arterial Disease (PAD)
    • 2.2.4 Deep Vein Thrombosis (DVT)
    • 2.2.5 Pulmonary Embolism (PE)
  • 2.3 PATIENT DEMOGRAPHICS
    • 2.3.1 Aortic Aneurysms
    • 2.3.2 Atherosclerosis
    • 2.3.3 Peripheral Arterial Disease (PAD)
    • 2.3.4 Deep Vein Thrombosis (DVT)
    • 2.3.5 Pulmonary Embolism (PE)

PRODUCT ASSESSMENT

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS
    • 3.2.1 Peripheral Vascular Stent
    • 3.2.2 Venous Stent
    • 3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon
    • 3.2.4 Drug-Coated Balloon
    • 3.2.5 Atherectomy Device
    • 3.2.6 Chronic Total Occlusion (CTO) Device
    • 3.2.7 Intravascular Lithotripsy
    • 3.2.8 Surgical Graft
    • 3.2.9 Stent Graft
    • 3.2.10 Embolic Protection Device
    • 3.2.11 Peripheral Thrombus Management Device
    • 3.2.12 Inferior Vena Cava Filter
    • 3.2.13 Carotid Shunt
    • 3.2.14 Diagnostic and Interventional Catheters
    • 3.2.15 Diagnostic and Interventional Guidewire
    • 3.2.16 Introducer Sheath
    • 3.2.17 Vascular Closure Device (VCD)
    • 3.2.18 Transcatheter Embolization Device
    • 3.2.19 Peripheral IVUS Catheter
  • 3.3 REGULATORY ISSUES AND RECALLS
    • 3.3.1 Abbott
      • 3.3.1.1 Carotid Shunt
      • 3.3.1.2 Vascular Closure Device
    • 3.3.2 Argon Medical
      • 3.3.2.1 Introducer Sheaths
    • 3.3.3 Arrow International
      • 3.3.3.1 Introducer Sheaths
    • 3.3.4 Atrium Medical
      • 3.3.4.1 Peripheral Vascular Stent
    • 3.3.5 BD
      • 3.3.5.1 Inferior Vena Cava Filter
      • 3.3.5.2 Introducer Sheaths
      • 3.3.5.3 Stent Graft
    • 3.3.6 Boston Scientific
      • 3.3.6.1 Atherectomy Devices
      • 3.3.6.2 Diagnostic and Interventional Catheters
      • 3.3.6.3 Introducer Sheaths
      • 3.3.6.4 Peripheral Thrombus Management Devices
    • 3.3.7 Cardinal Health
      • 3.3.7.1 Vascular Closure Devices
    • 3.3.8 Cardiovascular System (C.S.I.)
      • 3.3.8.1 Atherectomy Devices
    • 3.3.9 Cook Medical
      • 3.3.9.1 Diagnostic and Interventional Catheters
      • 3.3.9.2 Introducer Sheaths
      • 3.3.9.3 Inferior Vena Cava Filters
      • 3.3.9.4 Peripheral Vascular Stents
      • 3.3.9.5 Stent Grafts
    • 3.3.10 Cordis (Cardinal Health)
      • 3.3.10.1 Diagnostic and Interventional Catheters
      • 3.3.10.2 Inferior Vena Cava Filters
      • 3.3.10.3 Peripheral Stents
    • 3.3.11 Endologix
      • 3.3.11.1 Stent Grafts
    • 3.3.12 Edwards Lifesciences
      • 3.3.12.1 Chronic Total Occlusion Devices
    • 3.3.13 Maquet
      • 3.3.13.1 PTA Balloons
    • 3.3.14 Medtronic
      • 3.3.14.1 Carotid Shunts
      • 3.3.14.2 Diagnostic and Interventional Catheters
      • 3.3.14.3 PTA Balloon Catheters
      • 3.3.14.4 Peripheral Stents
      • 3.3.14.5 Stent Grafts
      • 3.3.14.6 Transcatheter Embolization Devices
    • 3.3.15 Spectranetics (Philips)
      • 3.3.15.1 Atherectomy Devices
      • 3.3.15.2 Chronic Total Occlusion Devices
    • 3.3.16 Shockwave Medical, Inc.
      • 3.3.16.1 Intravascular Lithotripsy
    • 3.3.17 Terumo
      • 3.3.17.1 Introducer Sheaths
      • 3.3.17.2 PTA Balloon Catheters
    • 3.3.18 Other Companies
      • 3.3.18.1 Atherectomy Devices
      • 3.3.18.2 Introducer Sheaths
      • 3.3.18.3 PTA Balloon Catheters
      • 3.3.18.4 Peripheral IVUS Catheters
      • 3.3.18.5 Stent Grafts
      • 3.3.18.6 Vascular Closure Devices (VCD)
  • 3.4 CLINICAL TRIALS
    • 3.4.1 Abbott
      • 3.4.1.1 Peripheral Vascular Stent
      • 3.4.1.2 Other Peripheral Vascular Related Studies
    • 3.4.2 B. Braun
      • 3.4.2.1 Diagnostic and Interventional Catheters
      • 3.4.2.2 Peripheral Vascular Stent
    • 3.4.3 Boston Scientific
      • 3.4.3.1 Atherectomy Devices
      • 3.4.3.2 Drug-Coated Balloons
      • 3.4.3.3 Peripheral Vascular Stents
      • 3.4.3.4 Other Peripheral Vascular Related Studies
      • 3.4.3.5 Venous Stents
    • 3.4.4 C.R. Bard (BD)
      • 3.4.4.1 Diagnostic and Interventional Catheters
      • 3.4.4.2 Drug-Coated Balloons
      • 3.4.4.3 Venous Stents
      • 3.4.4.4 Other Peripheral Vascular Related Studies
    • 3.4.5 Cardinal Health
      • 3.4.5.1 Other Peripheral Vascular Related Studies
    • 3.4.6 Cook Medical
      • 3.4.6.1 Drug-Eluting Stents
      • 3.4.6.2 Inferior Vena Cava Filters
      • 3.4.6.3 Peripheral Vascular Stents
      • 3.4.6.4 Venous Stents
    • 3.4.7 Cordis (Cardinal Health)
      • 3.4.7.1 Peripheral Vascular Stents
    • 3.4.8 Medtronic
      • 3.4.8.1 Atherectomy Devices
      • 3.4.8.2 Drug-Coated Balloons
      • 3.4.8.3 Other Peripheral Vascular Related Studies
    • 3.4.9 Merit Medical
      • 3.4.9.1 Stent Grafts
    • 3.4.10 Philips/Spectranetics
      • 3.4.10.1 Atherectomy Devices
      • 3.4.10.2 Peripheral IVUS Catheters
      • 3.4.10.3 Spectranetics
      • 3.4.10.3.1 Drug-Coated Balloons
      • 3.4.10.3.2 Atherectomy Devices
    • 3.4.11 Shockwave Medical, Inc.
      • 3.4.11.1 Lithoplasty System
    • 3.4.12 Surmodics
      • 3.4.12.1 Drug-Coated Balloons
    • 3.4.13 Terumo
      • 3.4.13.1 Drug-Coated Balloons
      • 3.4.13.2 Peripheral Vascular Stents
    • 3.4.14 W.L. Gore
      • 3.4.14.1 Peripheral Vascular Stents
      • 3.4.14.2 Stent Grafts
      • 3.4.14.3 Expandable Balloons
    • 3.4.15 Other Companies
      • 3.4.15.1 Carotid Shunt / Endarterectomy
      • 3.4.15.2 Drug-Coated Balloons
      • 3.4.15.3 Peripheral Vascular Stents
      • 3.4.15.4 Other Peripheral Vascular Related Studies

U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW

  • 4.1 INTRODUCTION
    • 4.1.1 Atherosclerosis
    • 4.1.2 Peripheral Arterial Disease (PAD)
  • 4.2 MARKET OVERVIEW
  • 4.3 TREND ANALYSIS BY SEGMENT
  • 4.4 DRIVERS AND LIMITERS
    • 4.4.1 Market Drivers
    • 4.4.2 Market Limiters
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6 MERGERS AND ACQUISITIONS
  • 4.7 COMPANY PROFILES
    • 4.7.1 Abbott
    • 4.7.2 Becton Dickinson (BD)
    • 4.7.3 Boston Scientific
    • 4.7.4 Cardinal Health
      • 4.7.4.1 Cordis (Cardinal Health)
    • 4.7.5 Cook Medical
    • 4.7.6 Maquet
    • 4.7.7 Medtronic
    • 4.7.8 Teleflex
    • 4.7.9 Terumo Interventional System (TIS)
    • 4.7.10 W.L. Gore
  • 4.8 SWOT ANALYSIS
    • 4.8.1 Abbott
    • 4.8.2 B. Braun
    • 4.8.3 Boston Scientific
    • 4.8.4 BD
    • 4.8.5 Cardinal Health
    • 4.8.6 Cook Medical
    • 4.8.7 Integra Lifesciences
    • 4.8.8 Maquet
    • 4.8.9 Medtronic
    • 4.8.10 Merit Medical
    • 4.8.11 Phillips
    • 4.8.12 Teleflex
    • 4.8.13 Terumo
    • 4.8.14 W.L. Gore

PROCEDURE NUMBERS

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURES
    • 5.2.1 Total Peripheral Vascular Procedures
    • 5.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting
      • 5.2.2.1 Above-the-Knee Procedures
      • 5.2.2.1.1 Above-the-Knee Stent Procedures
      • 5.2.2.1.2 Above-the-Knee POBA Procedures by Care Setting
      • 5.2.2.1.3 Above-the-Knee DCB Procedures by Care Setting
      • 5.2.2.1.4 Above-the-Knee Atherectomy without Stent Procedures by Care Setting
      • 5.2.2.1.5 Above-the-Knee Atherectomy with Stent Procedures by Care Setting
      • 5.2.2.2 Below-the-Knee Procedures
      • 5.2.2.2.1 Below-the-Knee Stent Procedures by Device Type
      • 5.2.2.2.2 Below-the-Knee Stent Procedures by Care Setting
      • 5.2.2.2.3 Below-the-Knee POBA Procedures by Care Setting
      • 5.2.2.2.4 Below-the-Knee DCB Procedures by Care Setting
      • 5.2.2.2.5 Below-the-Knee Atherectomy without Stent Procedures by Care Setting
      • 5.2.2.2.6 Below-the-Knee Atherectomy with Stent Procedures by Care Setting
      • 5.2.2.3 Iliac Procedures
      • 5.2.2.3.1 Iliac Stent Procedures by Device Type
      • 5.2.2.3.2 Iliac Stent Procedures by Care Setting
      • 5.2.2.3.3 Iliac POBA Procedures by Care Setting
      • 5.2.2.4 AV Access Procedures
      • 5.2.2.4.1 AV Access Covered Stent Procedures by Care Setting
      • 5.2.2.4.2 AV Access POBA Procedures by Care Setting
      • 5.2.2.4.3 AV Access DCB Procedures by Care Setting
      • 5.2.2.5 Renal Procedures
      • 5.2.2.6 Carotid Procedures
    • 5.2.3 Peripheral Vascular Stent Procedures
      • 5.2.3.1 Peripheral Arterial Stent Procedures by Stent Type
      • 5.2.3.1.1 Bare-Metal Stent Procedures
      • 5.2.3.1.2 Covered Stent Procedures
      • 5.2.3.1.3 Drug-Eluting Stent Procedures
    • 5.2.4 Peripheral Venous Stent
    • 5.2.5 PTA Balloon Catheter Procedures
    • 5.2.6 Drug-Coated Balloon Procedures
      • 5.2.6.1 Drug-Coated Balloon Procedures by Indication
    • 5.2.7 Atherectomy Procedures
      • 5.2.7.1 Atherectomy Procedures by Device Type